Ofatumumab

In the US, Ofatumumab (ofatumumab systemic) is a member of the drug class CD20 monoclonal antibodies and is used to treat Chronic Lymphocytic Leukemia.

US matches:

• Ofatumumab


• Ofatumumab Intravenous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01XC10

CAS registry number (Chemical Abstracts Service)

0679818-59-8

Chemical Formula

C6480-H10022-N1742-O2020-S44

Molecular Weight

146060

Therapeutic Category

Antineoplastic agent

Foreign Names

• Ofatumumabum (Latin)
• Ofatumumab (German)
• Ofatumumab (French)
• Ofatumumab (Spanish)

Generic Names

• 2F2 (IS)
• GSK-1841157 (IS)
• HuMax-CD20 (IS)
• UNII-M95KG522R0 (IS)

Brand Names

• Arzerra
  GlaxoSmithKline, United Kingdom; GlaxoSmithKline, United States

International Drug Name Search

Glossary

IS	Inofficial Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.